Ascendis Health Limited (JSE:ASC)

Market Cap	575.69M +27.8%
Revenue (ttm)	n/a
Net Income	11.28M -80.3%
EPS	0.02 -80.3%
Shares Out	625.75M
PE Ratio	51.07
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	120,719
Open	96.00
Previous Close	92.00
Day's Range	92.00 - 96.00
52-Week Range	71.00 - 113.00
Beta	0.20
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 24, 2025

About Ascendis Health

Ascendis Health Limited, a health and wellness company, provides health and wellness products and clinical and diagnostic medical devices in South Africa. It operates in Consumer Health and Medical Devices segments. The company offers multivitamins and minerals, micronutrients, and nutraceutical supplements; vitamins and homeopathic and herbal products; and over-the-counter, complementary, alternative consumer, skin, and scripted compounding products under the Solal, Solal Skincare, Chela-Preg, Bettaway, Chela-fer, Jungle-Vites, Vitaforce, and ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2008
• Employees: 14
• Stock Exchange: Johannesburg Stock Exchange
• Ticker Symbol: ASC

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Dec 10, 2025

Data Sources Report a data error